BioCentury
ARTICLE | Company News

Alza's Ditropan XL approved in Canada

June 11, 2001 7:00 AM UTC

Canada granted marketing approval for AZA's Ditropan XL once daily controlled release oxybutynin to treat urge urinary incontinence. The product is approved in the U.S. and the U.K. ...